Investigation of mast cell-stimulating factors using blood from subjects with chronic spontaneous urticaria

Hayama Koremasa0 个研究点目标入组 35 人开始时间: 2023年5月26日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients with chronic spontaneous urticaria (CSU)
•1)Patients who were diagnosed as chronic spontaneous urticaria following the criteria of the Japanese Dermatological Association Guidelines.
•2)Patients who were not administered any medications other than antihistamines and adjunctive therapies as defined by the guidelines of the Japanese Dermatological Association, with symptom of urticaria at least 4 times a week for more than 4 weeks and persisting for more than 4 weeks, moderate and severe CSU patients (UAS7 >= 16, ISS7 >= 6 and HSS7 >= 6), and who had never received omalizumab.
•3)Patients aged between 16 and 70 years at the time of consent,regardless of gender
•Healthy control subjects
•1)Subjects aged between 16 and 70 years at the time of consent,regardless of gender
•2)Subjects who are not diagnosed as chronic spontaneous urticaria following the criteria of the Japanese Dermatological Association

•Patients with chronic spontaneous urticaria who were administered corticosteroids or immunosuppressive drugs within 4 weeks prior to the study

发起方

Hayama Koremasa